Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
clinical trials
fda
life sciences
national blog main
akouos
astellas pharmaceuticals
bill & melinda gates foundation
biotech ipos
boston top stories
california institute for biomedical research
ceo
co-founder
deals
decibel therapeutics
disease
dyne therapeutics
frequency therapeutics
gates foundation
harvard university
health
healthcare
hearing loss
hiv
investing
jeffrey karp
lawyer
massachusetts institute of technology
medication
metacrine
multiple sclerosis
myotonic dystrophy type 1
nonalcoholic steatohepatitis
perceptive life sciences
pharmacy
polaris partners
rare disease drugs
rare diseases
What
developing
3
×
drug
3
×
therapeutics
3
×
company
ipo
medicines
million
raised
acting
affects
aiming
americans
approved
brings
change
consumption
continue
creating
date
delayed
delivery
disorders
dyne
dyne’s
fda
frequency
genetic
hearing
kind
little
long
loss
lyndra
mecha
medicine
meds
millions
muscle
muscular
new
Language
unset
Current search:
drug
×
therapeutics
×
developing
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@techcrunch.com
5 years ago
Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 million
